MVCAX | NQVAX | MVCAX / NQVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 23 years | 22 years | - |
Gain YTD | 2.966 | 3.379 | 88% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 2500 | 40% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 17.6B | 508M | 3,465% |
Annual Yield % from dividends | 1.16 | 0.98 | 119% |
Returns for 1 year | 9.50 | 24.66 | 39% |
Returns for 3 years | 2.65 | 38.38 | 7% |
Returns for 5 years | 30.79 | 78.04 | 39% |
Returns for 10 years | 74.34 | 153.26 | 49% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MLRSX | 12.35 | 0.13 | +1.06% |
NYLI Winslow Large Cap Growth Class R6 | |||
SDGZX | 124.65 | 1.16 | +0.94% |
DWS Capital Growth R6 | |||
SGMIX | 9.85 | 0.04 | +0.41% |
SEI Global Managed Volatility I (SIMT) | |||
EMAAX | 14.81 | 0.05 | +0.34% |
Gabelli Entpr Mergers & Acquisitions A | |||
PVCMX | 12.22 | -0.01 | -0.08% |
Palm Valley Capital Investor |